• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CVS Health® 2025 Rx Report highlights transformation of community pharmacy to meet patient needs

    10/14/25 8:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $CVS alert in real time by email

    CVS Health/Morning Consult survey reveals patients trust and prefer local pharmacy care, want expanded services in community pharmacy

    Number of pharmacy technicians who want to become pharmacists has increased significantly since 2024

    WOONSOCKET, R.I., Oct. 14, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) today released the 2025 Rx Report: Community Pharmacy Reimagined, which explores how community pharmacies are adapting to meet patient demand while supporting pharmacy teams and addressing industry challenges with sustainable models of care.

    CVS Health (PRNewsFoto/CVS Health)

    "As one of the most trusted health care brands, CVS Pharmacy® is committed to delivering personalized, accessible care that meets patients where they are," said Len Shankman, Executive Vice President and President of Pharmacy and Consumer Wellness, CVS Health. "Our latest Rx Report shows that patients want more care from their local pharmacies, and pharmacy teams are ready to provide it. By combining the power of human connection with innovative digital tools and a more sustainable reimbursement model, we're building the future of community pharmacy today."

    The 2025 Rx Report is based on a CVS Health survey of more than 2,200 consumers and more than 1,060 pharmacists and pharmacy technicians1, revealing several trends:

    • Community pharmacies are convenient and accessible. Nearly eight in 10 U.S. adults report visiting a pharmacy in the past year, with 42% prioritizing personalized, convenient care.
    • Trust in pharmacists remains strong. More than three-quarters (77%) of adults trust their local pharmacist, and 84% view pharmacies as credible sources of health care.
    • In-person care remains essential. 80% of patients prefer face-to-face pharmacy care, and nearly half (48%) would switch pharmacies if limited to digital-only options. The overwhelming majority of pharmacy professionals (97%) also say in-person interactions remain vital.
    • Pharmacy teams want to expand their roles. Seventy-five percent of retail pharmacy professionals aspire to provide more care for their patients.
    • Technology can enhance care and support pharmacy teams. 65% of retail pharmacists are interested in integrating technology into their roles to enhance their day-to-day work, creating efficiencies and enabling more time for patient care.
    • Future generations need support: 40% of pharmacy technicians are interested in becoming pharmacists, up significantly year over year, underscoring the need for scholarships and training programs.

    "Community pharmacy teams do so much more than fill prescriptions and, as patients increasingly rely on them for local access to care, we are reimagining the role they play to have an even greater impact on public health," said Lucille Accetta, Senior Vice President and Chief Pharmacy Officer, CVS Health. "It's why we're continuing to develop new ways to support our colleagues, giving them more time to care for patients, advancing smart public policy that enables them to play an expanded care role and helping to champion the next generation of community pharmacists."

    A community health destination

    The recent CVS Health survey data indicates that patients prefer face-to-face care over digital-only options. CVS Pharmacy's approach is tech-enabled but powered by colleagues – prioritizing the long-standing trust of pharmacy teams in local communities and using technology in innovative new ways to enhance pharmacist-patient interactions.

    To meet growing patient needs in local communities, CVS Pharmacy is also expanding access by opening nearly 100 new community locations this year — including more than 60 acquired from Rite Aid in the Pacific Northwest. The company is also launching new small-format stores in underserved areas, which will offer full prescription services, immunizations, refills and medication support, along with a curated selection of health essentials.

    Smart technology supports pharmacy teams and patients

    Survey results also highlight the importance of supporting pharmacy teams, with two-thirds of retail pharmacists saying technology integration can improve workflow and patient care. CVS Pharmacy continues to invest in innovations that support its pharmacy colleagues, including a dynamic workload-sharing model, SmartDUR™ drug utilization review system, and a modernized pharmacy operating system developed with input from colleagues themselves.

    Expanding the role of community pharmacy

    An expanded scope of practice – such as prescribing certain medications – is among the top changes pharmacy professionals want to see in the industry over the next several years. CVS Pharmacy has expanded the types of care and services it provides – from administering more than a dozen vaccines to testing for certain illnesses and prescribing certain therapies, where allowed by state law, and performing comprehensive medication reviews. But there is still more that both pharmacists and technicians can do to play an expanded role in public health.

    It is why the company is also advocating for public policy solutions that support sustainable pharmacy care. This includes supporting the Ensuring Community Access to Pharmacy Services Act of 2025 (H.R. 3164/S.2426), which would help preserve access to pharmacist-led testing and services that have become mainstays since the COVID-19 pandemic.

    Advancing a sustainable pharmacy model

    The report underscores the need for new reimbursement models to stabilize community pharmacies, as traditional market-basket approaches have challenged community pharmacies.

    CVS CostVantage™, the company's cost-based pricing framework, establishes reimbursement based on actual drug cost, a defined markup and a dispensing fee, delivering transparency for payors while ensuring fair compensation for pharmacy services. In 2026, the company plans to transition several government services programs to the cost-based pricing model.

    Investing in the next generation

    CVS Health is also addressing workforce sustainability with investments in tuition assistance, scholarships and partnerships with pharmacy schools. Through programs such as the PharmD Tuition Assistance Program and partnerships with the American Association of Colleges of Pharmacy and Duquesne University, CVS Health is helping to prepare tomorrow's pharmacy leaders.

    Community pharmacy is at an inflection point. To meet rising demand and market pressures, the industry must evolve by combining technology that drives convenience with the human connections patients trust most. With more than 9,000 community health destinations and a 60-year legacy of innovation, CVS Pharmacy is reimagining what local pharmacy care can be — because the future starts now.

    The full 2025 Rx Report can be downloaded at CVSHealth.com/Rx-Report.

    About CVS Health

    CVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of June 30, 2025, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics, a leading pharmacy benefits manager with approximately 87 million plan members, and a dedicated senior pharmacy care business serving more than 800,000 patients per year. The Company also serves an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including highly rated Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.

    Media Contact

    Shannon Dillon

    (346) 291-7131

    [email protected]

    Amy Thibault

    (401) 318-2865

    [email protected] 

    1 Morning Consult Survey Methodology: This survey was conducted online by Morning Consult between June 2 – June 25, 2025, among a sample of more than 1,060 pharmacists and pharmacy technicians, and 2,200 general consumers in the United States. The data from the pharmacist and pharmacy technicians were left unweighted, while the data from general consumers were weighted to approximate a target sample of U.S. adults based on age, gender, race/ethnicity, region, and educational attainment.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-2025-rx-report-highlights-transformation-of-community-pharmacy-to-meet-patient-needs-302580006.html

    SOURCE CVS Health

    Get the next $CVS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CVS

    DatePrice TargetRatingAnalyst
    10/14/2025$91.00Buy
    Goldman
    8/18/2025$79.00Neutral → Buy
    UBS
    8/14/2025$82.00Neutral → Outperform
    Robert W. Baird
    2/13/2025$55.00 → $75.00Market Perform → Outperform
    Leerink Partners
    2/12/2025Neutral → Overweight
    Cantor Fitzgerald
    1/30/2025Hold → Buy
    Edward Jones
    12/3/2024$66.00Hold → Buy
    Deutsche Bank
    11/18/2024$60.00 → $66.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $CVS
    SEC Filings

    View All

    SEC Form 8-K filed by CVS Health Corporation

    8-K - CVS HEALTH Corp (0000064803) (Filer)

    9/22/25 4:19:42 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 144 filed by CVS Health Corporation

    144 - CVS HEALTH Corp (0000064803) (Subject)

    8/19/25 6:57:22 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 8-K filed by CVS Health Corporation

    8-K - CVS HEALTH Corp (0000064803) (Filer)

    8/15/25 4:10:49 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and Chief People Officer Capozzi Heidi B bought $4,589 worth of shares (80 units at $57.36) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    10/14/25 7:08:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: New insider Capozzi Heidi B claimed ownership of 5 shares (SEC Form 3)

    3/A - CVS HEALTH Corp (0000064803) (Issuer)

    10/14/25 7:06:56 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    EVP and Group President Shah Prem S covered exercise/tax liability with 6,995 shares, decreasing direct ownership by 10% to 60,632 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    9/2/25 4:42:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on CVS Health with a new price target

    Goldman initiated coverage of CVS Health with a rating of Buy and set a new price target of $91.00

    10/14/25 8:48:20 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health upgraded by UBS with a new price target

    UBS upgraded CVS Health from Neutral to Buy and set a new price target of $79.00

    8/18/25 8:45:28 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded CVS Health from Neutral to Outperform and set a new price target of $82.00

    8/14/25 8:02:24 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Financials

    Live finance-specific insights

    View All

    CVS Pharmacy completes acquisition of Rite Aid assets nationwide

    Company wraps up conversion of 63 former Rite Aid and Bartell Drugs stores in the Pacific Northwest and hundreds of prescription file buys across 15 states WOONSOCKET, R.I., Oct. 15, 2025 /PRNewswire/ -- CVS Pharmacy today announced the completion of its acquisition of select Rite Aid assets nationwide. In total, the company acquired and is now operating 63 former Rite Aid and Bartell Drugs stores in Idaho, Oregon and Washington. CVS Pharmacy also acquired the prescription files of 626 former Rite Aid and Bartell Drugs pharmacies in 15 states. As a result of the transactions, CVS Pharmacy is pleased to be serving more than nine million former Rite Aid and Bartell Drugs patients.

    10/15/25 8:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health to hold third quarter 2025 earnings conference call

    WOONSOCKET, R.I., Sept. 30, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, October 29th, 2025, at 8:00 a.m. ET to discuss third quarter 2025 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of June 30, 2025,

    9/30/25 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health declares quarterly dividend

    WOONSOCKET, R.I., Sept. 17, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on November 3, 2025, to holders of record on October 23, 2025. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of June 30, 2025, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and prima

    9/17/25 5:09:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CVS Health Corporation

    SC 13G - CVS HEALTH Corp (0000064803) (Subject)

    11/13/24 1:00:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G/A filed by CVS Health Corporation (Amendment)

    SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)

    2/13/24 5:02:40 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G/A filed by CVS Health Corporation (Amendment)

    SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)

    2/9/23 11:16:32 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Leadership Updates

    Live Leadership Updates

    View All

    CVS Health Helps Improve Access to More Affordable Fertility Treatments

    WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations. CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization (

    10/16/25 5:09:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Aetna 2026 Medicare Advantage plans deliver access to affordable, personalized care

    Providing access to affordable care $0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1, $0 copay for colonoscopies and mammograms at in-network providers$0 copay for annual Healthy Home Visit from a licensed Signify Health clinicianContinued investment in technology, tools and teams that support our members Commitment to supporting unique member needs — those living with chronic conditions and individuals dually eligible for both Medicare and MedicaidLeveraging the strength of the CVS Health family of companies to deliver differentiated member experiencesWOONSOCKET, R.I., Oct. 1, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced our 2026 Medi

    10/1/25 7:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health Announces Chief Financial Officer Transition Plan; Appoints Chief Medical Officer

    WOONSOCKET, R.I., April 8, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced two leadership updates. Brian Newman has been named executive vice president and chief financial officer designate, effective April 21. He will succeed current chief financial officer, Tom Cowhey, who will transition to serve as a strategic advisor to president and chief executive officer David Joyner, effective May 12.Amy Compton-Phillips, M.D., is the company's new executive vice president and chief medical officer, effective May 19, also reporting to David Joyner.Based on year-to-date res

    4/8/25 6:30:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and Chief People Officer Capozzi Heidi B bought $4,589 worth of shares (80 units at $57.36) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    10/14/25 7:08:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Sansone Guy P bought $100,009 worth of shares (1,570 units at $63.70), increasing direct ownership by 15% to 12,007 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/9/25 8:22:46 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Mahoney Michael F bought $2,001,000 worth of shares (30,000 units at $66.70), increasing direct ownership by 321% to 39,356 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    2/19/25 12:35:35 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CVS Health Helps Improve Access to More Affordable Fertility Treatments

    WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations. CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization (

    10/16/25 5:09:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Pharmacy completes acquisition of Rite Aid assets nationwide

    Company wraps up conversion of 63 former Rite Aid and Bartell Drugs stores in the Pacific Northwest and hundreds of prescription file buys across 15 states WOONSOCKET, R.I., Oct. 15, 2025 /PRNewswire/ -- CVS Pharmacy today announced the completion of its acquisition of select Rite Aid assets nationwide. In total, the company acquired and is now operating 63 former Rite Aid and Bartell Drugs stores in Idaho, Oregon and Washington. CVS Pharmacy also acquired the prescription files of 626 former Rite Aid and Bartell Drugs pharmacies in 15 states. As a result of the transactions, CVS Pharmacy is pleased to be serving more than nine million former Rite Aid and Bartell Drugs patients.

    10/15/25 8:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health® 2025 Rx Report highlights transformation of community pharmacy to meet patient needs

    CVS Health/Morning Consult survey reveals patients trust and prefer local pharmacy care, want expanded services in community pharmacy Number of pharmacy technicians who want to become pharmacists has increased significantly since 2024 WOONSOCKET, R.I., Oct. 14, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) today released the 2025 Rx Report: Community Pharmacy Reimagined, which explores how community pharmacies are adapting to meet patient demand while supporting pharmacy teams and addressing industry challenges with sustainable models of care. "As one of the most trusted health

    10/14/25 8:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples